线粒体靶向药物的研究进展

Progress in mitochondrial targeting drug delivery systems

  • 摘要: 电离辐射产生的活性氧(ROS)和自由基攻击DNA、脂质、蛋白质等生物大分子,造成机体细胞和组织的损伤。体内ROS主要来自线粒体,辐射造成线粒体损伤,使细胞内ROS持续增加。线粒体靶向抗氧化剂由于靶向在线粒体释放,能够高效地消除辐射导致的线粒体内过量ROS,保护线粒体,降低电离辐射对细胞的损伤,被认为是一类有前景的辐射损伤防护药。近年来,文献报道了多种线粒体靶向给药系统,笔者主要分析了线粒体靶向给药系统的方法及其发展趋势以及在辐射防护上的应用潜能。

     

    Abstract: Free radicals and reactive oxygen species(ROS) generated by ionizing radiation attack vital macromolecules, such as DNA, lipids and Proteins, thus causing cell and tissue damage. The major source of radiation-induced ROS production is believed to be associated with mitochondria. Removal of excessive mitochondrial reactive oxygen species by electron scavengers and antioxidants is a promising therapeutic strategy to reduce the detrimental effects of radiation exposure. Mitochondrial targeting antioxidants and electron scavengers have been suggested as promising radioprotectors due to their well ability to remove of excessive mitochondrial reactive oxygen species. Papers about mitochondrial targeting drug delivery systems have been publicated in recent years. Technique of mitochondrial targeting drug delivery system, potential application in radiation protection and its development trend are discussed in this review.

     

/

返回文章
返回